Labone Cocaine Metabolite Micro-Plate Eia
by Labone, Inc.
510(k) K040198
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK040198 | Date5 Mar 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DIO
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3250
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Labone Cocaine Metabolite Micro-Plate Eia is an enzyme immunoassay for the detection of cocaine and cocaine metabolites. It is a competitive micro-plate immunoassay that uses an antibody coated on the solid surface of a micro-well to bind with cocaine metabolite in the sample.
The device is supplied as a micro-plate and is intended for use in laboratory testing procedures. It is regulated under 21 CFR 862.3250 and has been cleared by the FDA under the 510(k) number K040198. The device is used to monitor the precision and accuracy of laboratory testing procedures for cocaine metabolite.
Other devices from Labone, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the Labone Cocaine Metabolite Micro-Plate EIA used for?
The Labone Cocaine Metabolite Micro-Plate EIA is used for the detection of cocaine and cocaine metabolites in laboratory testing procedures, helping to monitor precision and accuracy.
How is the device supplied?
The device is supplied as a micro-plate, intended for use in laboratory settings.
Is the Labone Cocaine Metabolite Micro-Plate EIA regulated?
Yes, the device is regulated under 21 CFR 862.3250 and has been cleared by the FDA under the 510(k) number K040198, indicating it is substantially equivalent to a predicate device.